JPRN-UMIN000022844
Recruiting
未知
Research of mechanism and cytotoxicity of newly-developed anticancer drug for gastric cancer using human gastric cells. - Mechanism and cytotoxicity of newly-developed anticancer drug for gastric cancer.
ConditionsGastric cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Gastric cancer
- Sponsor
- Asahikawa Medical University
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The subjects who are judged to be inappropriate for this study by doctors conducting the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Vitamin C as an anti-cancer drugEUCTR2008-008692-33-DKDepartment of Urology, Herlev Hospital
Recruiting
Phase 1
hR3 MAb in combination with chemo-embolization in hepatocellular carcinoma.Hepatocellular carcinomaLiver NeoplasmsCarcinoma, HepatocellularDigestive System NeoplasmsLiver DiseasesDigestive System DiseasesAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialRPCEC00000022Center of Molecular Immunology (CIM)15
Recruiting
Phase 1
hR3 monoclonal antibody combined with chemoembolization in mestatatic liver treatment.Primary malignant colon and breast lesion and metastatic liver lesions.Liver NeoplasmsDigestive System NeoplasmsLiver DiseasesDigestive System DiseasesRPCEC00000023Center of Molecular Immunology (CIM)15
Completed
Phase 3
Evaluation of copper and zinc quantity in saliva, released from copper oxide and zinc oxide nanoparticles coated attachments used for fixed orthodontic treatment in patients having tooth malalignmentCTRI/2023/08/056249il36
Recruiting
Not Applicable
Molecular biological study to elucidate pathogenicity of epicardial adipose tissueJPRN-UMIN000043455Hiroshima University50